Additional Information

Description

ILUMYA® Tildrakizumab-asmn 100 mg / mL Injection Prefilled Syringe 1 mL is a medication indicated for the treatment of adults diagnosed with moderate-to-severe plaque psoriasis who are suitable candidates for systemic therapy or phototherapy. Manufactured by Sun Pharmaceutical Industries Inc, this injection comes in a sterile, preservative-free solution. It appears clear to slightly opalescent, ranging from colorless to slightly yellow in hue.

Contained within a prefilled syringe, the medication belongs to the category of Interleukin-23 Antagonists. Each prefilled syringe contains a dosage of 100 mg / mL of the generic drug Tildrakizumab-asmn. The product is designed for subcutaneous administration and requires refrigeration for storage to maintain its stability and efficacy.

This medication offers a convenient and reliable option for individuals seeking treatment for plaque psoriasis, providing a standardized dosage in a user-friendly format. With its targeted mechanism of action, ILUMYA® offers a promising therapeutic solution for managing the symptoms of moderate-to-severe plaque psoriasis, addressing the needs of patients and healthcare providers alike.